Observed data
Within individual embryos
Agreement in heteroplasmy levels between different parts of the same embryo
Panels A and B show the same blastocysts (n = 40). Panel C also includes 22 cleavage-stage embryos from one woman carrying m.3243A>G (Monnot et al., 2011; two blastomeres per embryo).
Key finding. Heteroplasmy levels are usually similar between samples from the same blastocyst. The median within-embryo range is 1.2 percentage points, or 2.2 percentage points for pathogenic variants (maximum 8 percentage points). In 76% of blastocysts with pathogenic variants, the range is 5 percentage points or less.
A. Samples from the same embryo
B. Difference: analysed sample − clinical biopsy sample
C. Within-embryo range
Select a point to view its source and provenance. grey band — ±5 percentage points; an illustrative guide without a published source. Ranges calculated from three samples (11 embryos) and two samples (29) are not directly comparable; median — red bar.
Median range: 2.2 pp (21 blastocysts with pathogenic variants), 1 pp (HV2), 1.2 pp (all 40); cleavage stage — 1 pp (n = 22).
Data table (n = 40)
n = 40
| Embryo | mtDNA variant | Source | TE biopsy sample | ICM | Remaining TE | Combined ICM+TE sample | Range (max − min), pp |
|---|---|---|---|---|---|---|---|
| Janssen2024_F20_E45 | m.3243A>G | Janssen et al., 2024 | 49.6% | — | 49.5% | — | 0.1 |
| Janssen2024_F20_E46 | m.3243A>G | Janssen et al., 2024 | 67.1% | — | 67.7% | — | 0.6 |
| Janssen2024_F20_E47 | m.3243A>G | Janssen et al., 2024 | 75.6% | — | 76.3% | — | 0.7 |
| Janssen2024_F20_E48 | m.3243A>G | Janssen et al., 2024 | 40.8% | — | 38.6% | — | 2.2 |
| Rubens_113 | HV2 polymorphism | Rubens et al., 2025 | 85% | — | 84% | — | 1 |
| Rubens_114 | HV2 polymorphism | Rubens et al., 2025 | 82% | — | 86% | — | 4 |
| Rubens_115 | HV2 polymorphism | Rubens et al., 2025 | 95% | — | 96% | — | 1 |
| Rubens_116 | HV2 polymorphism | Rubens et al., 2025 | 91% | 91% | 88% | — | 3 |
| Rubens_117 | HV2 polymorphism | Rubens et al., 2025 | 54% | 53% | 56% | — | 3 |
| Rubens_118 | HV2 polymorphism | Rubens et al., 2025 | 83% | — | 82% | — | 1 |
| Rubens_120 | HV2 polymorphism | Rubens et al., 2025 | 93% | 100% | 93% | — | 7 |
| Rubens_123 | HV2 polymorphism | Rubens et al., 2025 | 90% | 90% | 88% | — | 2 |
| Rubens_125 | HV2 polymorphism | Rubens et al., 2025 | 94% | — | 93% | — | 1 |
| Rubens_126 | HV2 polymorphism | Rubens et al., 2025 | 95% | — | 94% | — | 1 |
| Rubens_127 | HV2 polymorphism | Rubens et al., 2025 | 100% | — | 100% | — | 0 |
| Rubens_128 | HV2 polymorphism | Rubens et al., 2025 | 100% | 100% | 100% | — | 0 |
| Rubens_129 | HV2 polymorphism | Rubens et al., 2025 | 100% | — | 100% | — | 0 |
| Rubens_130 | HV2 polymorphism | Rubens et al., 2025 | 100% | — | 100% | — | 0 |
| Rubens_131 | HV2 polymorphism | Rubens et al., 2025 | 100% | 100% | 100% | — | 0 |
| Rubens_132 | HV2 polymorphism | Rubens et al., 2025 | 100% | 100% | 100% | — | 0 |
| Rubens_134 | HV2 polymorphism | Rubens et al., 2025 | 100% | — | 100% | — | 0 |
| Rubens_135 | HV2 polymorphism | Rubens et al., 2025 | 100% | — | 100% | — | 0 |
| Rubens_136 | HV2 polymorphism | Rubens et al., 2025 | 100% | — | 100% | — | 0 |
| Rubens_55 | m.8344A>G | Rubens et al., 2025 | 68% | 76% | — | — | 8 |
| Rubens_56 | m.8344A>G | Rubens et al., 2025 | 70% | — | 70% | — | 0 |
| Rubens_57 | m.8344A>G | Rubens et al., 2025 | 74% | 80% | — | — | 6 |
| Rubens_61 | m.8344A>G | Rubens et al., 2025 | 76% | 82% | — | — | 6 |
| Rubens_105 | m.8993T>C | Rubens et al., 2025 | 69% | — | 73% | — | 4 |
| Tofilo_1 | m.14487T>C | Tofilo et al., 2026 | 11.4% | 12.2% | 12.9% | — | 1.5 |
| Tofilo_2 | m.14487T>C | Tofilo et al., 2026 | 99.6% | 99.6% | 100% | — | 0.4 |
| Tofilo_3 | m.14487T>C | Tofilo et al., 2026 | 12% | — | — | 13.5% | 1.5 |
| Tofilo_4 | m.14487T>C | Tofilo et al., 2026 | 92.3% | — | — | 90% | 2.3 |
| Tofilo_5 | m.14487T>C | Tofilo et al., 2026 | 73.2% | 72.3% | 78.7% | — | 6.4 |
| Tofilo_6 | m.14487T>C | Tofilo et al., 2026 | 13.5% | 11.3% | 11.7% | — | 2.2 |
| Treff_blastocyst_1 | m.3243A>G | Treff et al., 2012 | 23.67% | 25% | — | — | 1.33 |
| Treff_blastocyst_2 | m.3243A>G | Treff et al., 2012 | 81.67% | 81% | — | — | 0.67 |
| Treff_blastocyst_3 | m.3243A>G | Treff et al., 2012 | 91.25% | 85% | — | — | 6.25 |
| Treff_blastocyst_4 | m.3243A>G | Treff et al., 2012 | 88.33% | 91% | — | — | 2.67 |
| Treff_blastocyst_5 | m.3243A>G | Treff et al., 2012 | 81.75% | 83.33% | — | — | 1.58 |
| Treff_blastocyst_6 | m.3243A>G | Treff et al., 2012 | 36.33% | 39.33% | — | — | 3 |
Additional data: 16 samples from one blastocyst (Hu et al., 2026) extended view
A blastocyst with 17.8% m.3250T>C in the biopsy sample was divided into 16 samples of 3–5 cells; the ICM was not isolated. These data are not plotted because variability among small cell samples is not directly comparable with variability among larger embryo fractions.
| # | Cells | Depth, × | m.3250T>C, % | Δ vs 17.8% |
|---|---|---|---|---|
| 1 | TE/ICM (3) | 93,314 | 18.1 | 0.3 |
| 2 | TE/ICM (3) | 92,970 | 17.7 | -0.1 |
| 3 | TE/ICM (3) | 93,329 | 16.9 | -0.9 |
| 4 | TE/ICM (3) | 92,752 | 16.3 | -1.5 |
| 5 | TE/ICM (3) | 93,852 | 18.7 | 0.9 |
| 6 | TE/ICM (5) | 95,633 | 19.7 | 1.9 |
| 7 | TE/ICM (5) | 93,532 | 20.3 | 2.5 |
| 8 | TE/ICM (5) | 95,184 | 17.5 | -0.3 |
| 9 | TE/ICM (5) | 96,602 | 20.4 | 2.6 |
| 10 | TE/ICM (5) | 97,201 | 21.9 | 4.1 |
| 11 | TE/ICM (5) | 94,356 | 14.7 | -3.1 |
| 12 | TE (3) | 94,815 | 18.6 | 0.8 |
| 13 | TE (3) | 95,156 | 16.9 | -0.9 |
| 14 | TE (3–5) | 94,114 | 18.5 | 0.7 |
| 15 | TE (3–5) | 94,218 | 17.5 | -0.3 |
| 16 | TE (5) | 93,083 | 17.5 | -0.3 |